Myopia ProgressionPhase 3NCT07535749
The Effect of Myopia-Control Contact Lenses in New Zealand Chinese Children
A Phase 3 study testing MiSight Contact Lenses (CooperVision) and Albiliti 1-Day (Johnson and Johnson, VisionCare) in people with Myopia Progression, run by Aston University at 1 site in New Zealand.
Trial summary
The study will employ a randomized, controlled, investigator-masked paired-eye comparison design to evaluate the effects of two myopia-control contact lenses-MiSight 1 Day and Abiliti 1-Day-in New Zealand Chinese children. Read more about this study
- Who is it for?
- Ages 7 to 11 years
- Conditions the study is for
- Myopia Progression
- What is being tested?
- MiSight Contact Lenses (CooperVision) and Albiliti 1-Day (Johnson and Johnson, VisionCare)
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 66 participants
- Where
- 1 siteNew Zealand
- Study dates
- 21 Mar 2026to 30 May 2027
- Phase
- Phase 3
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 7 to 11 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Spherical refractive error between -1.00D and -4.50D
- Astigmatism of ≤1.00D
- No history of orthokeratology or atropine use
- No ocular diseases or surgical history
Who cannot join
- o No ocular diseases or surgical history
Trial locations and contacts
1 site in 1 country.
About this study
The study will employ a randomized, controlled, investigator-masked paired-eye comparison design to evaluate the effects of two myopia-control contact lenses-MiSight 1 Day and Abiliti 1-Day-in New Zealand Chinese children.
The study duration will be 12 months, with assessments conducted at baseline, 2 weeks, 3 months, 6 months and 12 months.
The clinical research will be conducted at the Auckland Myopia Clinic (New Zealand) and will follow a standard clinical routine for children with early myopia, the only difference being the randomizing of the MiSight and Abiliti contact lenses between the two eyes of the participants.
Read the detailed description
- Study Design The study will employ a randomized, controlled, investigator-masked paired-eye comparison design to evaluate the effects of two myopia-control contact lenses-MiSight 1 Day and Abiliti 1-Day-in New Zealand Chinese children. The study duration will be 6 months, with assessments conducted at baseline, 2 weeks, 3 months, and 6 months. The clinical research will be conducted at the Auckland Myopia Clinic (New Zealand) and will follow a standard clinical routine for children with early myopia, the only difference being the randomizing of the MiSight and Abiliti contact lenses between the two eyes of the participants.
- Participants 2.1 Recruitment and Eligibility Criteria • Participants: 53-66 New Zealand Chinese children aged 7-11 years.
- Inclusion criteria:
- Spherical refractive error between -1.00D and -4.50D
- Astigmatism of ≤1.00D
- No history of orthokeratology or atropine use
- No ocular diseases or surgical history
- Recruitment will be through social media, patient referrals, and school outreach. 2.2 Sample Size A similar study, of soft contact lenses with novel ring focus for controlling myopia progression, based their sample size on treatment efficacy of >0.08 mm (standard deviation [SD]: 0.10) in axial elongation from baseline and >0.20 D (SD: 0.32) in change of spherical equivalent cycloplegic autorefraction (SECAR) from baseline at 26 weeks. Controlling the 2-sided type I error rate at the 0.05 level, the researchers found that sample size of 40 subjects per group would yield >80% power for detecting treatment efficacy. To estimate the sample size for the present study, a priori power analysis was performed using the program G∗Power (version 3.1.9.7). For a 95% confidence interval (Z = 1.96) and a study power of 80%, and controlling the 2-sided type I error rate at the 0.05 level, the estimated sample size is 53 pairs of eyes (53 subjects), as each participant contributes both eyes to the study. Providing for a 20% dropout rate, the recruitment target becomes 66 participants.
- Interventions Each participant will wear:
- MiSight 1 Day dual-focus lens in one eye (2.00D defocus)
- Abiliti 1-Day lens in the contralateral eye (7.00D defocus)
- Data Collection Methods 4.1 Baseline and Follow-up Assessments
- Cycloplegic refraction (CycloRx) and retinoscopy (Ret) will be conducted.
- Axial length will be measured using MYAH optical biometry.
- Ocular surface assessments:
- Children Dry Eye Questionnaire (CDEQ) responses
- Non-invasive Tear break-up time (NIBUT) using MYAH's dry eye function
- Ocular Protection Index (OPI) calculation using MYAH
- Corneal staining assessment via MYAH corneal staining and slit lamp fluorescein
- Lissamine green conjunctiva staining (graded and recorded) 4.2 Timepoints for Data Collection
- Baseline (0 months): Cycloplegic refraction, axial length, CDEQ, NIBUT, OPI, corneal staining.
- 2 weeks: Axial length, ocular surface assessments, dry eye symptoms.
- 3 months: Axial length, ocular surface assessments, dry eye symptoms.
- 6 months: Final assessments of axial length, ocular surface health, and dry eye symptoms.
- Outcome Measures
- Myopia-control efficacy: Comparison of axial length elongation between the two contact lenses.
- Ocular surface health:
- CDEQ responses
- NIBUT measurements
- OPI calculation
- Corneal staining severity Should one lens slow the development of myopia more than the other, the lenses will be reversed at the end of the study.
- Parent Perception Questionnaire
A structured questionnaire will be administered at baseline and at 6 months to assess parents' expectations and perceptions of the contact lenses as a myopia treatment. Topics covered include:
- Baseline Questionnaire: Motivations, barriers, facilitators, and expectations for contact lens treatment.
- Follow-up Questionnaire: Changes in attitudes, satisfaction with treatment compared to initial expectations, and future adherence.
- Ethical Considerations The study will comply with optometric ethical standards. Participants and parents will provide informed consent. Data confidentiality will be maintained, and the study will be subject to institutional ethics review.
- Study Personnel The study will be investigator-masked and conducted by two paediatric optometrists,who each have extensive experience in myopia management. Both have conducted over 800 paediatric myopia exams.
- Statistical Analysis Data will be analysed using SPSS software. Axial length changes will be compared between paired eyes using paired t-tests. Dry eye symptoms and corneal staining scores will be analysed using a repeated measures ANOVA.
- Conditions
- Myopia Progression
- Being tested
- MiSight Contact Lenses (CooperVision), Albiliti 1-Day (Johnson and Johnson, VisionCare)
- Keywords
- myopia control, contact lenses
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
MiSight Contact Lenses (CooperVision)Device
Myopia Control Contact Lens
Albiliti 1-Day (Johnson and Johnson, VisionCare)Device
Myopia Control Contact Lens
| Study group | Role | What they receive |
|---|---|---|
| MiSight Contact Lens | Active comparator | Commercially available myopia control contact lens Receives: Device: MiSight Contact Lenses (CooperVision) |
| Abiliti 1-Day | Active comparator | Commercially available myopia control contact lens Receives: Device: Albiliti 1-Day (Johnson and Johnson, VisionCare) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Mean Spherical Equivalent Cycloplegic Refraction
The dioptric refractive error as determined by retinoscopy following cycloplegic refraction
Measured: Baseline, 2 weeks, 3 months, 6 months, 12 months
Axial length
Ocular biometry measured with Myah biometer
Measured: Baseline, 2 weeks, 3 months, 6 months, 12 months
Secondary outcomes (5)
Children Dry Eye Questionnaire (CDEQ) response
Total score derived from the Children Dry Eye Questionnaire (CDEQ)
Measured: Baseline, 2 weeks, 3 months, 6 months, 12 months
Non-invasive Tear break-up time
Non-invasive Tear break-up time (NIBUT) using MYAH's objective dry eye function - time after a blink (in seconds) for the first break in the tear film to be detected
Measured: Baseline, 2 weeks, 3 months, 6 months, 12 months
Ocular Protection Index
Non-invasive breakup time secondary outcome measure divided by the average blink interval (number of blinks observed in a 60s period)
Measured: Baseline, 2 weeks, 3 months, 6 months, 12 months
Corneal punctate spots
Number of punctate spots observed on the cornea following instillation of fluorescein and illumination with a blue light source
Measured: Baseline, 2 weeks, 3 months, 6 months, 12 months
Conjunctival punctate spots
Number of puntate spots observed over the bulbar conjunctiva following instillation of lissamine green dye
Measured: Baseline, 2 weeks, 3 months, 6 months, 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Apr 2026
- Study start21 Mar 2026
- Primary completion30 Apr 2027 (estimated)
- Study completion30 May 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Myopia ProgressionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 3
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Contralateral eye study, randomised
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 66 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Aston University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07535749
- Sponsor's protocol ID
- Myopia-Control Contact Lenses
- Status last verified
- Sep 2026
- First submitted
- 24 Mar 2026
- Last updated
- 4 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Patients have not given permission for this
Study at a glance
From the registry record, last updated by the sponsor on 4 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Myopia-Control Contact Lenses in New Zealand Chinese Children
- ClinicalTrials.gov ID
- NCT07535749
- Acronym / sponsor ID
- Myopia-Control Contact Lenses
- Conditions
- Myopia Progression
- Keywords
- myopia control, contact lenses
- Phase
- Phase 3
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 66 participants (estimated)
- Lead sponsor
- Aston UniversityUniversity, hospital or other
- Study start
- 21 Mar 2026 (actual)
- Primary completion
- 30 Apr 2027 (estimated)
- Study completion
- 30 May 2027 (estimated)
- First posted
- 17 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study will employ a randomized, controlled, investigator-masked paired-eye comparison design to evaluate the effects of two myopia-control contact lenses-MiSight 1 Day and Abiliti 1-Day-in New Zealand Chinese children.
The study duration will be 12 months, with assessments conducted at baseline, 2 weeks, 3 months, 6 months and 12 months.
The clinical research will be conducted at the Auckland Myopia Clinic (New Zealand) and will follow a standard clinical routine for children with early myopia, the only difference being the randomizing of the MiSight and Abiliti contact lenses between the two eyes of the participants.
Detailed description
- Study Design The study will employ a randomized, controlled, investigator-masked paired-eye comparison design to evaluate the effects of two myopia-control contact lenses-MiSight 1 Day and Abiliti 1-Day-in New Zealand Chinese children. The study duration will be 6 months, with assessments conducted at baseline, 2 weeks, 3 months, and 6 months. The clinical research will be conducted at the Auckland Myopia Clinic (New Zealand) and will follow a standard clinical routine for children with early myopia, the only difference being the randomizing of the MiSight and Abiliti contact lenses between the two eyes of the participants.
- Participants 2.1 Recruitment and Eligibility Criteria • Participants: 53-66 New Zealand Chinese children aged 7-11 years.
- Inclusion criteria:
- Spherical refractive error between -1.00D and -4.50D
- Astigmatism of ≤1.00D
- No history of orthokeratology or atropine use
- No ocular diseases or surgical history
- Recruitment will be through social media, patient referrals, and school outreach. 2.2 Sample Size A similar study, of soft contact lenses with novel ring focus for controlling myopia progression, based their sample size on treatment efficacy of >0.08 mm (standard deviation [SD]: 0.10) in axial elongation from baseline and >0.20 D (SD: 0.32) in change of spherical equivalent cycloplegic autorefraction (SECAR) from baseline at 26 weeks. Controlling the 2-sided type I error rate at the 0.05 level, the researchers found that sample size of 40 subjects per group would yield >80% power for detecting treatment efficacy. To estimate the sample size for the present study, a priori power analysis was performed using the program G∗Power (version 3.1.9.7). For a 95% confidence interval (Z = 1.96) and a study power of 80%, and controlling the 2-sided type I error rate at the 0.05 level, the estimated sample size is 53 pairs of eyes (53 subjects), as each participant contributes both eyes to the study. Providing for a 20% dropout rate, the recruitment target becomes 66 participants.
- Interventions Each participant will wear:
- MiSight 1 Day dual-focus lens in one eye (2.00D defocus)
- Abiliti 1-Day lens in the contralateral eye (7.00D defocus)
- Data Collection Methods 4.1 Baseline and Follow-up Assessments
- Cycloplegic refraction (CycloRx) and retinoscopy (Ret) will be conducted.
- Axial length will be measured using MYAH optical biometry.
- Ocular surface assessments:
- Children Dry Eye Questionnaire (CDEQ) responses
- Non-invasive Tear break-up time (NIBUT) using MYAH's dry eye function
- Ocular Protection Index (OPI) calculation using MYAH
- Corneal staining assessment via MYAH corneal staining and slit lamp fluorescein
- Lissamine green conjunctiva staining (graded and recorded) 4.2 Timepoints for Data Collection
- Baseline (0 months): Cycloplegic refraction, axial length, CDEQ, NIBUT, OPI, corneal staining.
- 2 weeks: Axial length, ocular surface assessments, dry eye symptoms.
- 3 months: Axial length, ocular surface assessments, dry eye symptoms.
- 6 months: Final assessments of axial length, ocular surface health, and dry eye symptoms.
- Outcome Measures
- Myopia-control efficacy: Comparison of axial length elongation between the two contact lenses.
- Ocular surface health:
- CDEQ responses
- NIBUT measurements
- OPI calculation
- Corneal staining severity Should one lens slow the development of myopia more than the other, the lenses will be reversed at the end of the study.
- Parent Perception Questionnaire
A structured questionnaire will be administered at baseline and at 6 months to assess parents' expectations and perceptions of the contact lenses as a myopia treatment. Topics covered include:
- Baseline Questionnaire: Motivations, barriers, facilitators, and expectations for contact lens treatment.
- Follow-up Questionnaire: Changes in attitudes, satisfaction with treatment compared to initial expectations, and future adherence.
- Ethical Considerations The study will comply with optometric ethical standards. Participants and parents will provide informed consent. Data confidentiality will be maintained, and the study will be subject to institutional ethics review.
- Study Personnel The study will be investigator-masked and conducted by two paediatric optometrists,who each have extensive experience in myopia management. Both have conducted over 800 paediatric myopia exams.
- Statistical Analysis Data will be analysed using SPSS software. Axial length changes will be compared between paired eyes using paired t-tests. Dry eye symptoms and corneal staining scores will be analysed using a repeated measures ANOVA.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
- Model description
- Contralateral eye study, randomised
| Arm | Type | Receives |
|---|---|---|
| MiSight Contact Lens | Active comparator | Device: MiSight Contact Lenses (CooperVision)Commercially available myopia control contact lens |
| Abiliti 1-Day | Active comparator | Device: Albiliti 1-Day (Johnson and Johnson, VisionCare)Commercially available myopia control contact lens |
Who may qualify
- Ages
- 7 to 11 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (4 listed)
- Spherical refractive error between -1.00D and -4.50D
- Astigmatism of ≤1.00D
- No history of orthokeratology or atropine use
- No ocular diseases or surgical history
Key exclusion criteria (1 listed)
- o No ocular diseases or surgical history
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| MiSight Contact Lenses (CooperVision)Myopia Control Contact Lens | Device | MiSight Contact Lens |
| Albiliti 1-Day (Johnson and Johnson, VisionCare)Myopia Control Contact Lens | Device | Abiliti 1-Day |
Primary outcome
Mean Spherical Equivalent Cycloplegic Refraction
Time frame: Baseline, 2 weeks, 3 months, 6 months, 12 months
The dioptric refractive error as determined by retinoscopy following cycloplegic refraction
Axial length
Time frame: Baseline, 2 weeks, 3 months, 6 months, 12 months
Ocular biometry measured with Myah biometer
5 secondary outcomes
Children Dry Eye Questionnaire (CDEQ) response
Time frame: Baseline, 2 weeks, 3 months, 6 months, 12 months
Non-invasive Tear break-up time
Time frame: Baseline, 2 weeks, 3 months, 6 months, 12 months
Ocular Protection Index
Time frame: Baseline, 2 weeks, 3 months, 6 months, 12 months
Corneal punctate spots
Time frame: Baseline, 2 weeks, 3 months, 6 months, 12 months
Conjunctival punctate spots
Time frame: Baseline, 2 weeks, 3 months, 6 months, 12 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Sep 2026.
- Individual participant dataSharing planned: No. Patients have not given permission for this
Related trials for Myopia Progression
Not yet recruiting
BRIGHT-LIGHT: Studying Red Light Therapy for Severe Short-Sightedness or Short-Sightedness That Worsens Despite Standard Treatment
Myopia, Myopia Progressing
Not yet recruiting
The EYERISING Study
Myopia, Astigmatism
Recruiting
Mobility Performance in Daily Activities Among Children Wearing Spectacle Lenses
Myopia, Myopia Progression
Active, not recruiting
Correcting Myopia Among Secondary School Children to Increase Academic High School Attendance Rates in Rural Communities
Refractive Errors
Recruiting
Children's Viewing Behavior
Myopia, Myopia Progression
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 3 study testing MiSight Contact Lenses (CooperVision) and Albiliti 1-Day (Johnson and Johnson, VisionCare) in people with Myopia Progression, run by Aston University at 1 site in New Zealand.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 4 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in New Zealand. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Mean Spherical Equivalent Cycloplegic Refraction (time frame: Baseline, 2 weeks, 3 months, 6 months, 12 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Sep 2026.